Oriol S.
- Country
- Spain
- Department
- Pneumology Department
Research Overview
- A phase 2 trial of Gremubamab compared to placebo in participants with bronchiectasis and chronic Pseudomonas aeruginosa infection
- Efficacy and Safety Evaluation of Amikacin Liposome Inhalation Suspension with Azithromycin and Ethambutol in Adult Patients with MAC-Induced NTM Lung Infection
- Evaluation of Long-Term Safety and Efficacy of BI 1291583 in Patients with Bronchiectasis: A Randomized, Double-Blind, Parallel Group, Roll-Over Study
Data & Insights
Has run more than one trial at 66 of 210 partner sites.
Specializations
Respiratory Diseases
The investigator specializes in treating various forms of bronchiectasis, with particular emphasis on non-cystic fibrosis bronchiectasis (NCFB). Their work encompasses innovative therapeutic approaches for managing bronchial conditions and their complications.
- Bronchiectasis Management
- Pulmonary Exacerbation Treatment
- Respiratory Symptom Control
Infectious Disease Management
Focused on treating complex respiratory infections, particularly nontuberculous mycobacterial (NTM) lung infections and Pseudomonas aeruginosa infections. The investigator works with advanced therapeutic approaches for bacterial management in respiratory conditions.
- Mycobacterium Avium Complex (MAC) Treatment
- Chronic Bacterial Infection Control
- Antimicrobial Therapy
Therapeutic Innovations
The investigator explores novel therapeutic approaches including liposomal drug delivery systems and monoclonal antibody treatments for respiratory conditions. Their work includes evaluation of targeted biological therapies for bronchiectasis management.
- Inhaled Therapeutic Development
- Biological Treatment Applications
- Long-term Disease Management
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.